Litigation Details for Bionpharma Inc. v. Corerx, Inc. (S.D.N.Y. 2021)

Bionpharma Inc. v. Corerx, Inc. (S.D.N.Y. 2021)

Docket		Date Filed	2021-12-13
Court	District Court, S.D. New York	Date Terminated	2023-05-15
Cause	28:1332 Diversity Action	Assigned To	John George Koeltl
Jury Demand	None	Referred To	Valerie Figueredo
Patents	10,039,745; 10,154,987; 11,141,405; 9,669,008; 9,808,442
Link to Docket	External link to docket

Details for Bionpharma Inc. v. Corerx, Inc. (S.D.N.Y. 2021)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2022-02-02	69	Declaration in Support of Motion	of Azurity’s Epaned® patents (U.S. Patent Nos. 9,669,008, 9,808,442, 10,039,745, 10,154,987, 10,772,868… (D. Del.) (regarding the ’008, ’442, and ’745 Patents); Silvergate Pharm. Inc. v. Bionpharma …-1067-LPS (D. Del.) (regarding the ’987 Patent). Case 1:21-cv-10656-JGK Document 69 Filed… Del.) (regarding the ’008, ’442, and ’745 Patents); Silvergate Pharm. Inc. v. Bionpharma Inc.…. No. 19-1067-LPS (D. Del.) (regarding the ’987 Patent). 4. Attached hereto as Exhibit 3 is a true and	External link to document
2022-02-02	75	Declaration in Support of Motion	Nos. 9,669,008, 9,808,442, 10,039,745, 10,154,987, 10,772,868, 10,786,482, 10,799,476, 10,918,621, 11,040,023…several patents directed to stable oral liquid formulations of enalapril. These include U.S. Patent Nos.…Bionpharma for patent infringement by its generic drug product of several of the patents I identified …identified above. Later, after additional patents issued, Azurity brought additional suits for Bionpharma’s infringement…infringement of the newly obtained patents. Litigation concerning Bionpharma’s infringement is ongoing	External link to document